| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.0061 | 0.9 |
| mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | -0.0067 | 0.9 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.0094 | 0.9 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.0068 | 0.9 |
| mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | 0.0063 | 0.9 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | 0.013 | 0.9 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | -0.0064 | 0.9 |
| mRNA | palmostatin B | CTRPv2 | pan-cancer | AAC | 0.0083 | 0.9 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | -0.007 | 0.9 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | 0.01 | 0.9 |